MedTrace Logo

The Role of Circ0014614 in the Formation and Development of ET

NCT05921838 · Status: UNKNOWN · Type: OBSERVATIONAL · Enrollment: 120

Last updated 2023-06-27

No results posted yet for this study

Summary

Research on the Role of Circ0014614 in the Formation and Development of ET

Conditions

  • Primary Thrombocytosis

Interventions

OTHER

Sponsors & Collaborators

  • Nanfang Hospital, Southern Medical University

    lead OTHER

Principal Investigators

  • Dan Xu · Nanfang Hospital, Southern Medical University

Eligibility

Min Age
18 Years
Max Age
64 Years
Sex
ALL
Healthy Volunteers
No

Timeline & Regulatory

Start
2021-01-01
Primary Completion
2023-12-31
Completion
2023-12-31

Countries

  • China

Study Locations

More Related Trials

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT05921838 on ClinicalTrials.gov